Clinical Trials Logo

Cancer, Thyroid clinical trials

View clinical trials related to Cancer, Thyroid.

Filter by:
  • None
  • Page 1

NCT ID: NCT05783323 Recruiting - Cancer Clinical Trials

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

Start date: February 14, 2024
Phase: Phase 2
Study type: Interventional

Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve a complete response to RAI therapy, and this therapy carries the risk of pulmonary fibrosis and an increasingly recognized risk of secondary malignancies.

NCT ID: NCT03307694 Completed - Cancer, Thyroid Clinical Trials

Thyroid Ultrasound Elasticity (TrUE) Imaging

Start date: October 23, 2017
Phase:
Study type: Observational

In this study the researchers will scan the thyroid nodules of patients scheduled for surgical removal of these nodules. During their preadmission testing, but prior to their surgery, the researchers will perform standard ultrasound and shear wave elasticity imaging (SWEI) scans of the thyroid nodules in these patients. Both images can be generated by the same ultrasound scanner and within the same imaging session without having to switch out any equipment. The results of the SWEI scans will be compared to the definitive diagnosis from pathology obtained after pathologists have examined the removed nodules post-operatively.